348 related articles for article (PubMed ID: 30691944)
1. Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program.
Karamouzian M; Kuo M; Crabtree A; Buxton JA
Int J Drug Policy; 2019 Sep; 71():157-163. PubMed ID: 30691944
[TBL] [Abstract][Full Text] [Related]
2. Predictors of seeking emergency medical help during overdose events in a provincial naloxone distribution programme: a retrospective analysis.
Ambrose G; Amlani A; Buxton JA
BMJ Open; 2016 Jun; 6(6):e011224. PubMed ID: 27329442
[TBL] [Abstract][Full Text] [Related]
3. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with take-home naloxone kit usage in British Columbia: an analysis of administrative data.
Lei V; Ferguson M; Geiger R; Williams S; Liu L; Buxton JA
Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):25. PubMed ID: 35361228
[TBL] [Abstract][Full Text] [Related]
5. Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.
Moustaqim-Barrette A; Papamihali K; Mamdani Z; Williams S; Buxton JA
PLoS One; 2020; 15(9):e0238618. PubMed ID: 32915834
[TBL] [Abstract][Full Text] [Related]
6. Intention to seek emergency medical services during community overdose events in British Columbia, Canada: a cross-sectional survey.
Kievit B; Xavier JC; Ferguson M; Palis H; Moallef S; Slaunwhite A; Gillis T; Virk R; Buxton JA
Subst Abuse Treat Prev Policy; 2022 Jul; 17(1):56. PubMed ID: 35883186
[TBL] [Abstract][Full Text] [Related]
7. The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs.
Kim HK; Connors NJ; Mazer-Amirshahi ME
Expert Opin Drug Saf; 2019 Jun; 18(6):465-475. PubMed ID: 31033357
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with help seeking by community responders trained in overdose prevention and naloxone administration in Massachusetts.
Lim JK; Forman LS; Ruiz S; Xuan Z; Callis BP; Cranston K; Walley AY
Drug Alcohol Depend; 2019 Nov; 204():107531. PubMed ID: 31526959
[TBL] [Abstract][Full Text] [Related]
9. Correlates of take-home naloxone kit possession among people who use drugs in British Columbia: A cross-sectional analysis.
Moustaqim-Barrette A; Papamihali K; Crabtree A; Graham B; Karamouzian M; Buxton JA
Drug Alcohol Depend; 2019 Dec; 205():107609. PubMed ID: 31654839
[TBL] [Abstract][Full Text] [Related]
10. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.
Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M
Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621
[TBL] [Abstract][Full Text] [Related]
11. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
[TBL] [Abstract][Full Text] [Related]
12. How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies.
Neale J; Brown C; Campbell ANC; Jones JD; Metz VE; Strang J; Comer SD
Addiction; 2019 Apr; 114(4):708-718. PubMed ID: 30476356
[TBL] [Abstract][Full Text] [Related]
13. Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada.
Mayer S; Boyd J; Collins A; Kennedy MC; Fairbairn N; McNeil R
Drug Alcohol Depend; 2018 Dec; 193():69-74. PubMed ID: 30343236
[TBL] [Abstract][Full Text] [Related]
14. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
[TBL] [Abstract][Full Text] [Related]
15. Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study.
Moustaqim-Barrette A; Papamihali K; Williams S; Ferguson M; Moe J; Purssell R; Buxton JA
PLoS One; 2021; 16(10):e0259126. PubMed ID: 34714854
[TBL] [Abstract][Full Text] [Related]
16. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
17. Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose?
Koester S; Mueller SR; Raville L; Langegger S; Binswanger IA
Int J Drug Policy; 2017 Oct; 48():115-124. PubMed ID: 28734745
[TBL] [Abstract][Full Text] [Related]
18. The implementation and role of a staff naloxone program for non-profit community-based sites in British Columbia: A descriptive study.
Williams S; King T; Papamihali K; Buxton JA
PLoS One; 2021; 16(5):e0251112. PubMed ID: 33983996
[TBL] [Abstract][Full Text] [Related]
19. Estimating the total utilization of take home naloxone during an unregulated drug toxicity crisis: A Bayesian modeling approach.
Irvine MA; Bardwell S; Williams S; Liu L; Ge W; Kinniburgh B; Coombs D; Buxton JA
Int J Drug Policy; 2024 Jun; 128():104454. PubMed ID: 38788389
[TBL] [Abstract][Full Text] [Related]
20. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
